Cited by 343Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative DiseasesDown syndrome and intellectual disability research

Characterization and localization of the FMR-1 gene product associated with fragile X syndrome

Open access
Verheij, Coleta, Bakker, Cathy E., de Graaff, Esther, Keulemans, Joke, Willemsen, Rob, Verkerk, Annemieke J. M. H., Galjaard, Hans, Reuser, Arnold J. J. +2 more·1993·Nature

Abstract

The fragile X syndrome is the most frequent form of inherited mental retardation after Down's syndrome, having an incidence of one in 1,250 males. The fragile X syndrome results from amplification of the CGG repeat found in the FMR-1 gene. This CGG repeat shows length variation in normal individuals and is increased significantly in both carriers and patients; it is located 250 base pairs distal to a CpG island which is hypermethylated in fragile X patients. The methylation probably results in downregulation of FMR-1 gene expression. No information can be deduced about the function of the FMR-1 protein from its predicted sequence. Here we investigate the nature and function of the protein encoded by the FMR-1 gene using polyclonal antibodies raised against the predicted amino-acid sequences. Four different protein products, possibly resulting from alternative splicing, have been identified by immunoblotting in lymphoblastoid cell lines of healthy individuals. All these proteins were missing in cell lines from patients not expressing FMR-1 messenger RNA. The intracellular localization of the FMR-1 gene products was investigated by transient expression in COS-1 cells and found to be cytoplasmic. Localization was also predominantly cytoplasmic in the epithelium of the oesophagus, but in some cells was obviously nuclear.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/363722a0

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fragile X syndrome is a NDD where the causative gene, Fragile X Mental Retardation Protein (FMRP), is completely absent, causing a plethora of developmental abnormalities.

    “Fragile X syndrome (FX) is a NDD where the causative gene, Fragile X Mental Retardation Protein (FMRP), is completely absent causing a plethora of developmental abnormalities [264, 265].”

    From Development of prefrontal cortex (2022) · cites this paper as [265]

    The opening passage (p. 1) links fragile X syndrome to changes in the FMR-1 gene and reports that its protein products were missing in patient cell lines lacking FMR-1 mRNA. But the paper also reports FMRP expression in a mosaic patient (p. 2), so it does not support saying the protein is completely absent in all patients. FMRP is the gene product, not the gene; the paper discusses mental retardation and syndrome manifestations, but does not establish the claimed breadth of developmental abnormalities. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Verheij, C., Bakker, C. E., de Graaff, E., Keulemans, J., Willemsen, R., Verkerk, A. J. M. H., Galjaard, H., Reuser, A. J. J., Hoogeveen, A. T., & Oostra, B. A.
Affiliations
Erasmus University Rotterdam (NL)
Venue
Nature
Published
1993-06
Volume
363
Issue
6431
Pages
722-724
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1978236923
Cited by
343
References
18
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 8 · 2019: 8 · 2018: 6 · 2017: 9 · 2016: 8 · 2015: 14 · 2014: 10 · 2013: 13 · 2012: 9
FWCI
13.46
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
Keywords
fragile X syndrome, CGG repeat expansion, CpG island hypermethylation, alternative splicing, protein isoforms, gene downregulation, protein localization, cytoplasmic localization, esophageal epithelium
MeSH terms
Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cloning, Molecular, Cytoplasm, DNA, Single-Stranded, Escherichia coli, Fragile X Syndrome, Humans, Immunoenzyme Techniques, Male, Molecular Sequence Data, Mosaicism, Nerve Tissue Proteins, Precipitin Tests, Repetitive Sequences, Nucleic Acid, RNA, Messenger, Transfection, RNA-Binding Proteins, Alternative Splicing, Fragile X Messenger Ribonucleoprotein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review